A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia
Clinical trial NCT07295418 · COMPLETED
Trial details
- NCT number
- NCT07295418
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-23
- Primary completion
- 2025-04-22
- Enrollment
- 618
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.